CVE-2023-29863
CWE-89Published: May 11, 2023· Updated: Jul 9, 2026
Official Description
Medical Systems Co. Medisys Weblab Products v19.4.03 was discovered to contain a SQL injection vulnerability via the tem:statement parameter in the WSDL files.
Risk Analysis
Medical Systems Co. Medisys Weblab 19.4.03 is vulnerable to SQL injection via the tem:statement parameter in WSDL files. This critical flaw allows remote attackers to execute unauthorized database commands.
There is no known public exploit for this vulnerability, and it is not in the KEV database.
Update to the latest version of Medisys Weblab. Restrict access to WSDL files to authorized users only.
Technical Analysis
CVE-2023-29863 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.
The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.
A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 9.8.
From a weakness classification perspective (CWE-89): SQL injection vulnerabilities allow attackers to manipulate database queries, potentially exposing or modifying sensitive data.
CVSS v3.1 Vector Breakdown
Affected Vendors & Products
Exploit & PoC Resources
All References (2)
Quick Facts
Related CVEs (CWE-89)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2023-29863 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts